ClassID:

20918

A61K38/1709 - page 12 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3301
20140066388
2014-03-06

Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity

#3302
20140066368
2014-03-06

Methods For Affecting Body Composition

#3303
20140066366
2014-03-06

Methods of treating virally-infected living cells with histones

#3304
20140065240
2014-03-06

Methods and compositions relating to mesenchymal stem cell exosomes

#3305
20140065193
2014-03-06

ZSCAN4 as a marker for pancreatic stem cells and progenitor cells and use thereof

#3306
20140057849
2014-02-27

Wild-type apolipoprotein L-I for use in the prevention of kidney diseases

#3307
20140057838
2014-02-27

OSTEOBLAST-EXPRESSED LIPOCALIN 2 REGULATES GLUCOSE METABOLISM

#3308
20140056960
2014-02-27

Methods for Improving Fracture Healing and Bone Formation

#3309
20140051644
2014-02-20

Pharmaceutical composition for treating hyperproliferative diseases

#3310
20140051624
2014-02-20

Oxidant resistant apolipoprotein A-1 and mimetic peptides

#3311
20140050781
2014-02-20

Use of AGR3 for treating cancer

#3312
20140045758
2014-02-13

Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock

#3313
20140045749
2014-02-13

Method of treating a disease or condition characterised by aberrant epithelial cell proliferation

#3314
20140044770
2014-02-13

Compositions and methods for modulating BRD4 bioactivity

#3315
20140044644
2014-02-13

ANKYRIN G AND MODULATORS THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

#3316
20140038906
2014-02-06

Therapeutic and diagnostic methods involving biglycan and utrophin

#3317
20140037653
2014-02-06

Modulation of LRCH4 activity and therapeutic application thereof

#3318
20140037640
2014-02-06

Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease

#3319
20140037614
2014-02-06

THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5

#3320
20140031274
2014-01-30

Biological activity of placental protein 13

#3321
20140030274
2014-01-30

Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein

#3322
20140030240
2014-01-30

Methods and compositions for modulating PD1

#3323
20140024599
2014-01-23

Methods and compositions for treatment of disease or injury of the nervous system

#3324
20140024594
2014-01-23

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY

#3325
20140024588
2014-01-23

METHOD FOR INDUCING SUSTAINED IMMUNE RESPONSE

#3326
20140018305
2014-01-16

ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION

#3327
20140018302
2014-01-16

Cancer therapies and diagnostics

#3328
20140017274
2014-01-16

Method for the production of protein complexes and vaccine compositions comprising the same

#3329
20140017221
2014-01-16

Nucleic acid encoding superoxide dismutase variants and methods of use thereof

#3330
20140017201
2014-01-16

Viral vectors for the treatment of retinal dystrophy

#3331
20140011737
2014-01-09

Methods for treating metabolic syndrome with Cthrc1 polypeptide

#3332
20140010863
2014-01-09

LIPOSOMES FOR PROTECTION AGAINST TOXIC COMPOUNDS

#3333
20140010831
2014-01-09

Chimeric peptides comprising HER-2 B-cell epitopes and Tcell helper epitopes

#3334
20140010821
2014-01-09

Use of CD83 in combination therapies

#3335
20140005127
2014-01-02

Methods of treating muscular wasting diseases using NF-KB activation inhibitors

#3336
20140005120
2014-01-02

Activity enhancer for anticancer agent

#3337
20140005107
2014-01-02

Apolipoprotein AIV as an antidiabetic peptide

#3338
20140005105
2014-01-02

Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof

#3339
20140004545
2014-01-02

Compositions and methods for modulating the immune system

#3340
20140004196
2014-01-02

POLYAMIDE-AMINE DENDRIMER OR DERIVATIVE THEREOF-MATH1 GENE NANO PARTICLE AND USE THEREOF IN TREATMENT OF HEARING LOSS

#3341
20130345153
2013-12-26

Methods for treating burns-related systemic inflammatory response syndrome

#3342
20130345145
2013-12-26

ATIP3 AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF FOR USE IN THE TREATMENT OF CANCER

#3343
20130345113
2013-12-26

Method of Use of Activated Functional Proteins to Improve Animal Health

#3344
20130343998
2013-12-26

Control and characterization of memory function

#3345
20130338080
2013-12-19

COMPOSITIONS AND METHODS FOR TREATING AN ACTIVATED B-CELL DIFFUSE LARGE B-CELL LYMPHOMA

#3346
20130338069
2013-12-19

Preparation of a Therapeutic Composition

#3347
20130338065
2013-12-19

Dry powder inhaler and system for drug delivery

#3348
20130337557
2013-12-19

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases

#3349
20130337038
2013-12-19

Chimeric fibronectin matrix mimetics and uses therof

#3350
20130336966
2013-12-19

Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections

#3351
20130336955
2013-12-19

Antimicrobial fusion compounds and uses thereof

#3352
20130336950
2013-12-19

MATERIAL COMBINATION FOR TREATING INFLAMMATORY OR INFECTIOUS DISEASES

#3353
20130333059
2013-12-12

HOX COMPOSITIONS AND METHODS

#3354
20130331546
2013-12-12

Annexin II compositions

#3355
20130331343
2013-12-12

Materials presenting notch signaling molecules to control cell behavior

#3356
20130331329
2013-12-12

BIOMARKERS FOR SEIZURES

#3357
20130330455
2013-12-12

Process for producing a composition containing active follistatin

#3358
20130330333
2013-12-12

Treatment of angiogenesis disorders

#3359
20130330301
2013-12-12

Medical treatment composition comprising mammalian dental pulp stem cells

#3360
20130330294
2013-12-12

Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy

#3361
20130324472
2013-12-05

Therapeutic method for treating congestive heart failure

#3362
20130323264
2013-12-05

Diagnostic and therapeutic uses of moesin fragments

#3363
20130323200
2013-12-05

Gelsolin stimulation of blood samples using gold particles

#3364
20130318644
2013-11-28

Methods for treating disorders that involve immunoglobulin A

#3365
20130317090
2013-11-28

Inhibition of choroidal neovascularization

#3366
20130316946
2013-11-28

EXTENDED RECOMBINANT POLYPEPTIDE-MODIFIED C-PEPTIDE

#3367
20130315984
2013-11-28

Anti-trypanosomal peptides and uses thereof

#3368
20130315922
2013-11-28

Method for inducing lymphoid tissue and modulating intestinal homeostasis

#3369
20130310327
2013-11-21

Histatin for Corneal Wound Healing and Ocular Surface Disease

#3370
20130310326
2013-11-21

Histatin for Corneal Wound Healing and Ocular Surface Disease

#3371
20130310310
2013-11-21

Site-directed PEG-modified exendin-4 analogs and uses thereof

#3372
20130310307
2013-11-21

METHODS AND COMPOSITIONS FOR TREATMENT OF MULTIDRUG-RESISTANT BACTERIAL AND FUNGAL INFECTIONS

#3373
20130310305
2013-11-21

Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis

#3374
20130309208
2013-11-21

Medical treatment composition comprising mammalian dental pulp stem cells

#3375
20130309207
2013-11-21

Compositions comprising perivascular stem cells and nell-1 protein

#3376
20130303731
2013-11-14

Manufacture of factor H (FH) and FH-derivatives from plasma

#3377
20130303459
2013-11-14

Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain

#3378
20130302289
2013-11-14

Methods for modulating immune responses

#3379
20130295046
2013-11-07

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

#3380
20130295042
2013-11-07

Peptides and Peptide Mimetics to Treat Pathologies Associated With Eye Disease

#3381
20130291866
2013-11-07

Dry powder inhaler and system for drug delivery

#3382
20130289029
2013-10-31

Fused ring compound for use as mineralocorticoid receptor antagonist

#3383
20130288982
2013-10-31

THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA

#3384
20130288979
2013-10-31

Inhibitors of apoptosis and uses thereof

#3385
20130288965
2013-10-31

Use of peptides for promoting wound healing

#3386
20130288964
2013-10-31

Use of peptides for promoting wound healing

#3387
20130288961
2013-10-31

Methods for treating steatotic disease

#3388
20130287817
2013-10-31

Flowable implant with crosslinkable surface membrane

#3389
20130287760
2013-10-31

Treatment for dupuytren's disease

#3390
20130287738
2013-10-31

Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2

#3391
20130287726
2013-10-31

Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof

#3392
20130281356
2013-10-24

Methods and compositions for modulating Toso activity

#3393
20130280344
2013-10-24

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#3394
20130274191
2013-10-17

Compositions comprising β-arrestin 1 and methods of use thereof for therapeutic modulation of aldosterone levels in heart disease

#3395
20130274181
2013-10-17

Obesity-related genes and their proteins and uses thereof

#3396
20130274171
2013-10-17

TREFOIL FACTORS (TFF) FOR THE TREATMENT OF CHRONIC PULMONARY DISEASES

#3397
20130273558
2013-10-17

Screening methods for identifying Sp35 antagonists

#3398
20130273065
2013-10-17

Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal Tissues

#3399
20130267473
2013-10-10

Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins

#3400
20130267471
2013-10-10

Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

#3401
20130267470
2013-10-10

Treatment of penetrative injury to the brain

#3402
20130267456
2013-10-10

Therapeutic applications of SMAD7

#3403
20130261054
2013-10-03

Methods for treatment of nephrotic syndrome and related conditions

#3404
20130252879
2013-09-26

Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof

#3405
20130251675
2013-09-26

Methods for Modulating Inflammatory Responses

#3406
20130251651
2013-09-26

Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same

#3407
20130244927
2013-09-19

Compositions comprising signal peptide-containing proteins

#3408
20130243794
2013-09-19

METHODS FOR PREDICTING AND TREATING INFECTION-INDUCED ILLNESSES AND PREDICTING THE SEVERITY OF INFECTION-INDUCED ILLNESSES

#3409
20130236509
2013-09-12

MICROPARTICLES COMPRISING A SMALL HEAT-SHOCK PROTEIN

#3410
20130236426
2013-09-12

Use of decorin for increasing muscle mass

#3411
20130231280
2013-09-05

Novel Peptide Involved in Energy Homeostasis

#3412
20130230524
2013-09-05

Protein involved in ovarian cancer

#3413
20130230520
2013-09-05

Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain

#3414
20130230455
2013-09-05

USE OF GELSOLIN TO TREAT MULTIPLE SCLEROSIS AND TO DIAGNOSE NEUROLOGIC DISEASES

#3415
20130225503
2013-08-29

TEX14 PEPTIDES AS NOVEL ANTITUMOR AGENTS

#3416
20130217635
2013-08-22

NOVEL USE OF ERYTHROID DIFFERENTIATION REGULATOR 1 AS AN AGENT FOR TREATING CANCER

#3417
20130216537
2013-08-22

Methods of Treating Glucose Metabolism Disorders and Promoting Weight Loss

#3418
20130216504
2013-08-22

CCN3 and CCN3 peptides and analogs thereof for therapeutic uses

#3419
20130216503
2013-08-22

Methods for generating cardiomyocytes

#3420
20130203840
2013-08-08

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3421
20130203684
2013-08-08

Method of achieving a thymosin beta 4 concentration in a human patient

#3422
20130203658
2013-08-08

Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis

#3423
20130202680
2013-08-08

Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphin-gosine-1-phosphate

#3424
20130202533
2013-08-08

Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination

#3425
20130196950
2013-08-01

Retinoid replacements and opsin agonists and methods for the use thereof

#3426
20130196933
2013-08-01

Methods and compositions inhibiting tumor cell proliferation

#3427
20130196930
2013-08-01

Polynucleotides encoding recombinant lubricin molecules and uses thereof

#3428
20130196929
2013-08-01

SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS

#3429
20130196925
2013-08-01

Compositions and methods useful in enhancement of memory

#3430
20130196911
2013-08-01

Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands

#3431
20130196905
2013-08-01

Use of glycomacropeptide to improve women's health

#3432
20130195994
2013-08-01

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#3433
20130195993
2013-08-01

Purified amniotic membrane compositions and methods of use

#3434
20130195992
2013-08-01

Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment

#3435
20130195990
2013-08-01

Composition of whey growth factor extract for reducing muscle inflammation

#3436
20130195897
2013-08-01

Removal of serine proteases by treatment with finely divided silicon dioxide

#3437
20130195884
2013-08-01

NOVEL MODULATORS OF TRAIL SIGNALLING

#3438
20130195863
2013-08-01

Methods and Pharmaceutical Compositions for the Treatment of Bone Density Related Diseases

#3439
20130195856
2013-08-01

Methods of altering bone growth by administration of sost or wise antagonist or agonist

#3440
20130195837
2013-08-01

METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY

#3441
20130190226
2013-07-25

Reconstituted high density lipoprotein formulation and production method thereof

#3442
20130189253
2013-07-25

MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR

#3443
20130189225
2013-07-25

Methods of increasing efficiency of vector penetration of target tissue

#3444
20130184336
2013-07-18

Pharmaceutical composition for suppressing angiogenesis, and method for screening active material for suppressing angiogenesis

#3445
20130184224
2013-07-18

METHODS FOR INHIBITING TUMOR GROWTH

#3446
20130184211
2013-07-18

Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of chronic kidney disease and symptoms and/or complications thereof

#3447
20130183318
2013-07-18

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

#3448
20130183265
2013-07-18

MIA-2 PROTEIN

#3449
20130178410
2013-07-11

METHODS FOR MODULATING SLOW MYOSIN

#3450
20130177595
2013-07-11

Nano-vehicle derived from tumor tissue, and cancer vaccine using same

#3451
20130177549
2013-07-11

Treatment of synucleinopathies

#3452
20130177545
2013-07-11

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof

#3453
20130177525
2013-07-11

Cancer therapy based on tumor associated antigens derived from cyclin D1

#3454
20130172418
2013-07-04

Pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder

#3455
20130172399
2013-07-04

Selective inhibition of polyglutamine protein expression

#3456
20130172275
2013-07-04

Pharmaceutical compositions including a portion of the C-terminus of FGF23

#3457
20130171236
2013-07-04

Prevention and Treatment of Ischemia-Reperfusion Injury and Related Conditions

#3458
20130171158
2013-07-04

TREATMENT OF ABNORMALITIES OF GLUCOSE METABOLISM WITH AN ANTAGONIST OF INHIBITOR OF DIFFERENTIATION 1

#3459
20130165391
2013-06-27

β2-glycoprotein I peptide inhibitors

#3460
20130165384
2013-06-27

Decellularized small particle tissue

#3461
20130165369
2013-06-27

METHOD OF TREATING OBESITY AND METABOLIC DISORDERS RELATED TO EXCESS ADIPOSE TISSUE BY ADMINISTRATION OF sFRP-- PEPTIDE

#3462
20130164215
2013-06-27

Compositions and methods for detecting, diagnosing, and treating cancer

#3463
20130157937
2013-06-20

Stable high lipid liquid formula

#3464
20130157932
2013-06-20

NGAL AND URINARY TRACT INFECTION

#3465
20130156884
2013-06-20

PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME

#3466
20130156694
2013-06-20

HSP70 fusion protein conjugates and uses thereof

#3467
20130150432
2013-06-13

Improving efficacy of cancer therapy

#3468
20130150293
2013-06-13

Method for promoting regeneration of pancreatic beta-cells by administering neurturin

#3469
20130150284
2013-06-13

Immobilized biologically active entities having a high degree of biological activity

#3470
20130144260
2013-06-06

Device and method for the controlled delivery of ophthalmic solutions

#3471
20130143814
2013-06-06

Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration

#3472
20130143811
2013-06-06

Compositions comprising spp24 peptide fragments

#3473
20130143318
2013-06-06

Compositions for inhibition of RNA polymerase I and methods of production and use thereof

#3474
20130142816
2013-06-06

Administration of transfer factor for improving reproductive health

#3475
20130142760
2013-06-06

ATHEROSCLEROSIS INHIBITION VIA MODULATION OF MONOCYTE-MACROPHAGE PHENOTYPE USING APO A-I MILANO GENE TRANSFER

#3476
20130140390
2013-06-06

Retractor

#3477
20130137639
2013-05-30

Stable MIA/CD-RAP formulation

#3478
20130136738
2013-05-30

Methods of Treating Glucose Metabolism Disorders

#3479
20130136731
2013-05-30

Protein fusion constructs possessing thrombolytic and anticoagulant properties

#3480
20130130976
2013-05-23

Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases

#3481
20130130975
2013-05-23

Methods of treating glucose metabolism disorders

#3482
20130130971
2013-05-23

Method for inhibiting HIV replication in mammal and human cells

#3483
20130129814
2013-05-23

Regional delivery of therapeutic agents for the treatment of vascular diseases

#3484
20130129708
2013-05-23

Self-renewal promoter for neural stem cells and method for using same

#3485
20130129621
2013-05-23

Integrin receptor antagonists and their methods of use

#3486
20130123201
2013-05-16

MODULATION OF CYTOKINE-INDUCED CHRONIC INFLAMMATORY RESPONSES

#3487
20130123198
2013-05-16

Modulation of scleraxis using a dominant negative scleraxis mutant with a basic DNA-binding domain deletion

#3488
20130123188
2013-05-16

Methods for diagnosing and treating alzheimer's disease (AD) using the molecules that stabilize intracellular calcium (Ca) release

#3489
20130123185
2013-05-16

METHODS OF TREATING AND DIAGNOSING ACUTE CHEST SYNDROME

#3490
20130123168
2013-05-16

HUMANIN AND HUMANIN-ANALOGUES FOR THE MANAGEMENT OF ATHEROSCLEROSIS

#3491
20130122075
2013-05-16

ENCAPSULATED TRANSFER FACTOR COMPOSITIONS AND METHODS OF USE

#3492
20130121985
2013-05-16

Method and pharmacological composition for the diagnosis and treatment of male sub-fertility

#3493
20130116201
2013-05-09

Use of peptides as transporters intended for the internalization of molecules of interest into target cells

#3494
20130115278
2013-05-09

Peptide epitopes of apolipoprotein B

#3495
20130115277
2013-05-09

Peptide epitopes of apolipoprotein B

#3496
20130115276
2013-05-09

Peptide epitopes of apolipoprotein B

#3497
20130115275
2013-05-09

Peptide epitopes of apolipoprotein B

#3498
20130115225
2013-05-09

Reducer of immunosuppression by tumor cell and antitumor agent using the same

#3499
20130115221
2013-05-09

HIFα hydroxylation assay

#3500
20130109635
2013-05-02

Humanin Decreases Liver Fat and Visceral Fat Accumulation

#3501
20130109634
2013-05-02

Casein peptide for use in the treatment of uterine infections

#3502
20130109615
2013-05-02

METHODS FOR INHIBITING NECROSIS

#3503
20130108649
2013-05-02

Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection

#3504
20130102656
2013-04-25

Use of a granulin or a granulin-like compound for the therapy or prophylaxis of chronic pain

#3505
20130102541
2013-04-25

METHODS OF INHIBITING TUMOR CELL AGGRESSIVENESS USING THE MICROENVIRONMENT OF HUMAN EMBRYONIC STEM CELLS

#3506
20130102537
2013-04-25

Manufacture of factor H (FH) and FH-derivatives from plasma

#3507
20130101579
2013-04-25

Method to produce an immunoglobulin preparation with improved yield

#3508
20130101573
2013-04-25

Degradation resistant HSP70 formulations and uses thereof

#3509
20130095127
2013-04-18

METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN)

#3510
20130095075
2013-04-18

Bone morphogenic protein binding peptide

#3511
20130089528
2013-04-11

Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes

#3512
20130085096
2013-04-04

REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO

#3513
20130084327
2013-04-04

Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same

#3514
20130079286
2013-03-28

Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target

#3515
20130078264
2013-03-28

Removal of serine proteases by treatment with finely divided silicon dioxide

#3516
20130072568
2013-03-21

Retinoid replacements and opsin agonists and methods for the use thereof

#3517
20130072475
2013-03-21

Compositions and methods for the treatment of asthma and associated disorders

#3518
20130072446
2013-03-21

Anti-inflammatory pharmaceutical products

#3519
20130072443
2013-03-21

STABILIZED MUTANT OPSIN PROTEINS

#3520
20130072435
2013-03-21

Tribonectins

#3521
20130072425
2013-03-21

Saposin-A derived peptides and uses thereof

#3522
20130071393
2013-03-21

Isolated nucleotide sequences encoding GDF traps

#3523
20130071391
2013-03-21

Methods of Treating Glucose Metabolism Disorders

#3524
20130065242
2013-03-14

Methods for treating muscular dystrophy

#3525
20130064832
2013-03-14

NOTCH inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof

#3526
20130064818
2013-03-14

Use of immunesuppressant receptor

#3527
20130059798
2013-03-07

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

#3528
20130059786
2013-03-07

Kit for detecting Cthrc1 in a sample

#3529
20130059773
2013-03-07

COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND NEUTROPENIA

#3530
20130059772
2013-03-07

Use of Repeat Sequence Protein Polymers in Personal Care Compositions

#3531
20130058994
2013-03-07

LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS

#3532
20130058869
2013-03-07

Prevention And Treatment Of Amyloidogenic Disease

#3533
20130053330
2013-02-28

Fertilization prediction and promotion

#3534
20130053329
2013-02-28

METHODS OF INHIBITING APOPTOSIS OR INFLAMMATION IN A MAMMAL BY ADMINISTERING AN ISOLATED BCL PROTEIN

#3535
20130053328
2013-02-28

Methods of inhibiting photoreceptor apoptosis by eliciting the Faim2 antiapoptotic pathway

#3536
20130053313
2013-02-28

NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN

#3537
20130053306
2013-02-28

USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS

#3538
20130052198
2013-02-28

ANTI-INFLAMMATORY FACTORS

#3539
20130052167
2013-02-28

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#3540
20130052159
2013-02-28

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#3541
20130052157
2013-02-28

USE OF IL-17E FOR CANCER TREATMENT

#3542
20130045926
2013-02-21

COMPOSITION AND METHODS FOR THE PREVENTION AND TREATMENT OF MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND DIABETIC MACULAR EDEMA

#3543
20130045918
2013-02-21

Methods for treating diabetic wounds

#3544
20130045916
2013-02-21

TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF

#3545
20130045915
2013-02-21

Method for weight loss and ketogenic compositions

#3546
20130045216
2013-02-21

Method for treating amyloid disease

#3547
20130045191
2013-02-21

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#3548
20130039933
2013-02-14

STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES

#3549
20130039930
2013-02-14

BIOMARKER FOR SENSITIVITY TO THERAPY WITH A NOTCH INHIBITOR

#3550
20130039924
2013-02-14

Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases

#3551
20130039865
2013-02-14

Oral care compositions and methods

#3552
20130035371
2013-02-07

Lipid formulated dsRNA targeting the PCSK9 gene

#3553
20130035282
2013-02-07

Method of treating ischemic injury with follistatin-like 1 polypeptide

#3554
20130034568
2013-02-07

METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS

#3555
20130029912
2013-01-31

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis

#3556
20130028984
2013-01-31

Natural tissue scaffolds as tissue fillers

#3557
20130028896
2013-01-31

Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and uses

#3558
20130023485
2013-01-24

PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS

#3559
20130022994
2013-01-24

REGULATION OF BACE DEGRADATION

#3560
20130018001
2013-01-17

Methods of diagnosing cancer

#3561
20130017996
2013-01-17

Muteins of tear lipocalin and methods for obtaining the same

#3562
20130017994
2013-01-17

Methods of treating glucose metabolism disorders

#3563
20130012455
2013-01-10

Method for inhibiting cell death during liver failure by administering a caspase recruitment domain

#3564
20130012452
2013-01-10

Method for treating brain cancer using a novel tumor suppressor gene and secreted factor

#3565
20130012445
2013-01-10

Compositions for improving bone mass

#3566
20130012429
2013-01-10

ANTI-VIRAL THERAPY

#3567
20130011857
2013-01-10

COMPLEMENT FACTOR H FOR OXIDATIVE STRESS DISEASE CONDITIONS

#3568
20130011373
2013-01-10

SIDE POPULATION CELLS IN CARDIAC REPAIR

#3569
20130011366
2013-01-10

Therapeutic Agent for infections, and treatment method using the same

#3570
20130005795
2013-01-03

Use of Light Sensitive Genes

#3571
20130005645
2013-01-03

APOE PEPTIDE DIMERS AND USES THEREOF

#3572
20130004517
2013-01-03

DISC-1 pathway activators in the control of neurogenesis

#3573
20120331574
2012-12-27

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3574
20120329723
2012-12-27

Biological Agents Active in Central Nervous System

#3575
20120329722
2012-12-27

Method for enzymatically preparing peptides for use in improvement of brain function

#3576
20120329718
2012-12-27

Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor

#3577
20120329710
2012-12-27

Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues

#3578
20120329035
2012-12-27

Methods for improving sperm functionality

#3579
20120328690
2012-12-27

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#3580
20120328635
2012-12-27

Chaperonin 10 variants

#3581
20120322891
2012-12-20

Retinoid replacements and opsin agonists and methods for the use thereof

#3582
20120322742
2012-12-20

Therapeutics to inhibit MLL-menin interaction for treating leukemia

#3583
20120322723
2012-12-20

Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist

#3584
20120322689
2012-12-20

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3585
20120321693
2012-12-20

PRG4 treatment for interstitial cystitis

#3586
20120321645
2012-12-20

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins

#3587
20120321639
2012-12-20

Methods and compositions for the inhibition of Stat5 in prostate cancer cells

#3588
20120321594
2012-12-20

METHODS OF CONTROLLING AXON OR DENDRITE DEVELOPMENT OF NEURONAL CELLS

#3589
20120317664
2012-12-13

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

#3590
20120315274
2012-12-13

Methods of Treating Glucose Metabolism Disorders

#3591
20120311728
2012-12-06

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS

#3592
20120309788
2012-12-06

Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases

#3593
20120309685
2012-12-06

Purified EMD protein composition

#3594
20120309672
2012-12-06

Treatment of extracellular matrix to reduce inflammation

#3595
20120304321
2012-11-29

USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF

#3596
20120302504
2012-11-29

Method Of Reducing Injury To Mammalian Cells

#3597
20120302503
2012-11-29

PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF

#3598
20120301439
2012-11-29

INHIBITION OF CHOROIDAL NEOVASCULARIZATION

#3599
20120295835
2012-11-22

SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH

#3600
20120289472
2012-11-15

MOLECULES CAPABLE OF INDUCING CELL DEATH BY TARGETING THE MITOCHONDRIA AND APPLICATIONS THEREOF